NCT03147378View on ClinicalTrials.gov

Food Effect Study of ModraDoc006 in Combination With Ritonavir

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 10, 2017

Primary Completion Date

April 4, 2018

Study Completion Date

April 4, 2018

Conditions
Solid Tumor, Adult
Interventions
DRUG

ModraDoc006/r

Treatment with weekly ModraDoc006 (oral docetaxel) 10mg tablets in combination with ritonavir 100mg tablets in fed or fasting condition

Trial Locations (1)

1066 CX

Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam

Sponsors
All Listed Sponsors
collaborator

The Netherlands Cancer Institute

OTHER

lead

Modra Pharmaceuticals

INDUSTRY

NCT03147378 - Food Effect Study of ModraDoc006 in Combination With Ritonavir | Biotech Hunter | Biotech Hunter